Literature DB >> 11667527

Kahalalides: Bioactive Peptides from a Marine Mollusk Elysia rufescens and Its Algal Diet Bryopsis sp.(1).

Mark T. Hamann1, Clifton S. Otto, Paul J. Scheuer, D. Chuck Dunbar.   

Abstract

In addition to the previously reported bioactive kahalalide F six new peptides are described. Six of these, including kahalalide F, are cyclic depsipeptides, ranging from a C(31) tripeptide to a C(75) tridecapeptide isolated from a sacoglossan mollusk, Elysiarufescens. The mollusk feeds on a green alga, Bryopsis sp., which has also been shown to elaborate some of these peptides in smaller yields, in addition to an acyclic analog of F, kahalalide G. The bioassay results of antitumor, antiviral, antimalarial, and OI (activity against AIDS opportunistic infections) tests are reported.

Entities:  

Year:  1996        PMID: 11667527     DOI: 10.1021/jo960877+

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  48 in total

1.  Diversity of monomers in nonribosomal peptides: towards the prediction of origin and biological activity.

Authors:  Ségolène Caboche; Valérie Leclère; Maude Pupin; Gregory Kucherov; Philippe Jacques
Journal:  J Bacteriol       Date:  2010-08-06       Impact factor: 3.490

2.  In vitro and in vivo evaluation of select kahalalide F analogs with antitumor and antifungal activities.

Authors:  Abbas Gholipour Shilabin; Mark T Hamann
Journal:  Bioorg Med Chem       Date:  2011-06-25       Impact factor: 3.641

3.  Phase I, dose-escalating study of elisidepsin (Irvalec(®)), a plasma membrane-disrupting marine antitumor agent, in combination with erlotinib in patients with advanced malignant solid tumors.

Authors:  Sanjay Goel; Santiago Viteri; Teresa Morán; Cinthya Coronado; Jorge Luis Iglesias Dios; Bernardo Miguel-Lillo; Eva M Fernández-García; Rafael Rosell
Journal:  Invest New Drugs       Date:  2015-12-02       Impact factor: 3.850

Review 4.  Technology evaluation: Kahalalide F, PharmaMar.

Authors:  Mark T Hamann
Journal:  Curr Opin Mol Ther       Date:  2004-12

5.  Solid-phase total synthesis of kahalalide A and related analogues.

Authors:  Line Bourel-Bonnet; Karumanchi V Rao; Mark T Hamann; A Ganesan
Journal:  J Med Chem       Date:  2005-03-10       Impact factor: 7.446

Review 6.  Drug development from marine natural products.

Authors:  Tadeusz F Molinski; Doralyn S Dalisay; Sarah L Lievens; Jonel P Saludes
Journal:  Nat Rev Drug Discov       Date:  2008-12-19       Impact factor: 84.694

7.  Integrative species delimitation in photosynthetic sea slugs reveals twenty candidate species in three nominal taxa studied for drug discovery, plastid symbiosis or biological control.

Authors:  Patrick J Krug; Jann E Vendetti; Albert K Rodriguez; Jennifer N Retana; Yayoi M Hirano; Cynthia D Trowbridge
Journal:  Mol Phylogenet Evol       Date:  2013-07-19       Impact factor: 4.286

Review 8.  Microbial natural products: molecular blueprints for antitumor drugs.

Authors:  Lesley-Ann Giddings; David J Newman
Journal:  J Ind Microbiol Biotechnol       Date:  2013-09-03       Impact factor: 3.346

9.  Chemical defenses of the sacoglossan mollusk Elysia rufescens and its host Alga bryopsis sp.

Authors:  M A Becerro; G Goetz; V J Paul; P J Scheuer
Journal:  J Chem Ecol       Date:  2001-11       Impact factor: 2.626

10.  Cyclodepsipeptides from marine sponges: natural agents for drug research.

Authors:  Gowri Shankar Bagavananthem Andavan; Rosa Lemmens-Gruber
Journal:  Mar Drugs       Date:  2010-03-22       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.